Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Difference Between KLOW and KPV: Peptide Comparison

The table below summarizes the structural, functional, and practical research differences between KLOW and KPV for laboratory applications. Amino Acid Sequence Lys-Leu-Pro-Trp (tetrapeptide) Lys-Pro-Val (tripeptide) KLOW has one additional amino acid with arom

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The table below summarizes the structural, functional, and practical research differences between KLOW and KPV for laboratory applications.
  • Amino Acid Sequence
  • Lys-Leu-Pro-Trp (tetrapeptide)
  • Lys-Pro-Val (tripeptide)
  • KLOW has one additional amino acid with aromatic tryptophan
  • Molecular Weight
  • ~530 Da
  • ~341 Da
  • KLOW is 55% heavier, affecting diffusion and dosing
  • Receptor Selectivity
  • MC1R, MC3R, MC4R (broad)
  • MC1R, MC3R (selective)
  • KPV better for inflammation-specific studies
  • cAMP Kinetics
  • Rapid peak (15–20 min)
  • Sustained elevation (30–90 min)
  • KLOW for acute models, KPV for chronic protocols
  • Reconstitution Solubility
  • 5 mg/mL max (requires warming)
  • 10 mg/mL readily
  • KPV easier to handle at high concentrations
  • Storage Stability (2–8°C)
  • 30 days (light-sensitive)
  • 30+ days (light-stable)
  • KLOW requires amber vials or foil wrap
  • Freeze-Thaw Tolerance
  • Poor (avoid entirely)
  • Moderate (2 cycles max)
  • KPV more forgiving for multi-use protocols